» Articles » PMID: 29875478

On the Impact of Different Approaches to Classify Age-related Macular Degeneration: Results from the German AugUR Study

Overview
Journal Sci Rep
Specialty Science
Date 2018 Jun 8
PMID 29875478
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

While age-related macular degeneration (AMD) poses an important personal and public health burden, comparing epidemiological studies on AMD is hampered by differing approaches to classify AMD. In our AugUR study survey, recruiting residents from in/around Regensburg, Germany, aged 70+, we analyzed the AMD status derived from color fundus images applying two different classification systems. Based on 1,040 participants with gradable fundus images for at least one eye, we show that including individuals with only one gradable eye (n = 155) underestimates AMD prevalence and we provide a correction procedure. Bias-corrected and standardized to the Bavarian population, late AMD prevalence is 7.3% (95% confidence interval = [5.4; 9.4]). We find substantially different prevalence estimates for "early/intermediate AMD" depending on the classification system: 45.3% (95%-CI = [41.8; 48.7]) applying the Clinical Classification (early/intermediate AMD) or 17.1% (95%-CI = [14.6; 19.7]) applying the Three Continent AMD Consortium Severity Scale (mild/moderate/severe early AMD). We thus provide a first effort to grade AMD in a complete study with different classification systems, a first approach for bias-correction from individuals with only one gradable eye, and the first AMD prevalence estimates from a German elderly population. Our results underscore substantial differences for early/intermediate AMD prevalence estimates between classification systems and an urgent need for harmonization.

Citing Articles

Frequency of Atopic Dermatitis and Psoriasis in the Elderly: Cross-Sectional Findings from the German AugUR Study.

Drewitz K, Stark K, Zimmermann M, Heid I, Apfelbacher C Dermatology. 2024; 241(1):1-9.

PMID: 39342937 PMC: 11793095. DOI: 10.1159/000541590.


(rs1061170, rs1410996), (rs2071559, rs1870377) and KDR and CFH Serum Levels in AMD Development and Treatment Efficacy.

Cebatoriene D, Vilkeviciute A, Gedvilaite G, Bruzaite A, Kriauciuniene L, Zaliuniene D Biomedicines. 2024; 12(5).

PMID: 38790910 PMC: 11117782. DOI: 10.3390/biomedicines12050948.


Risk Factors of Age-Related Macular Degeneration in a Population-Based Study: Results from SHIP-TREND-1 (Study of Health in Pomerania-TREND-1).

Ludtke L, Ittermann T, Grossjohann R, Jurgens C, Volzke H, Tost F Med Sci Monit. 2024; 30:e943140.

PMID: 38702879 PMC: 11078065. DOI: 10.12659/MSM.943140.


Epidemiology of Diagnosed Age-related Macular Degeneration in Germany: An Evaluation of the Prevalence Using AOK PLUS Claims Data.

Schuster A, Leisle L, Picker N, Bubendorfer-Vorwerk H, Lewis P, Hahn P Ophthalmol Ther. 2024; 13(4):1025-1039.

PMID: 38386186 PMC: 10912065. DOI: 10.1007/s40123-024-00901-6.


Nuclear and mitochondrial genetic variants associated with mitochondrial DNA copy number.

Koller A, Filosi M, Weissensteiner H, Fazzini F, Gorski M, Pattaro C Sci Rep. 2024; 14(1):2083.

PMID: 38267512 PMC: 10808213. DOI: 10.1038/s41598-024-52373-0.


References
1.
Rosenfeld P . Bevacizumab versus ranibizumab for AMD. N Engl J Med. 2011; 364(20):1966-7. DOI: 10.1056/NEJMe1103334. View

2.
Wilde C, Poostchi A, Mehta R, MacNab H, Hillman J, Vernon S . Prevalence of age-related macular degeneration in an elderly UK Caucasian population-The Bridlington Eye Assessment Project: a cross-sectional study. Eye (Lond). 2017; 31(7):1042-1050. PMC: 5519272. DOI: 10.1038/eye.2017.30. View

3.
Korb C, Kottler U, Wolfram C, Hoehn R, Schulz A, Zwiener I . Prevalence of age-related macular degeneration in a large European cohort: results from the population-based Gutenberg Health Study. Graefes Arch Clin Exp Ophthalmol. 2014; 252(9):1403-11. DOI: 10.1007/s00417-014-2591-9. View

4.
Mitchell P, Smith W, Attebo K, Wang J . Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology. 1995; 102(10):1450-60. DOI: 10.1016/s0161-6420(95)30846-9. View

5.
Jonasson F, Arnarsson A, Eiriksdottir G, Harris T, Launer L, Meuer S . Prevalence of age-related macular degeneration in old persons: Age, Gene/environment Susceptibility Reykjavik Study. Ophthalmology. 2010; 118(5):825-30. PMC: 3087833. DOI: 10.1016/j.ophtha.2010.08.044. View